Praxis Impact Large Cap Value ETF (NYSEARCA:PRXV) Short Interest Down 93.0% in June

Praxis Impact Large Cap Value ETF (NYSEARCA:PRXV) was the target of a large decline in short interest in June. As of June 15th, there was short interest totaling 383 shares, a decline of 93.0% from the May 31st total of 5,485 shares. Based on an average daily trading volume, of 4,951 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the shares of the company are sold short.

Institutional Trading of Praxis Impact Large Cap Value ETF

An institutional investor recently raised its position in Praxis Impact Large Cap Value ETF stock. EverSource Wealth Advisors LLC lifted its stake in shares of Praxis Impact Large Cap Value ETF (NYSEARCA:PRXV) by 71.7% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,362,628 shares of the company’s stock after purchasing an additional 986,740 shares during the quarter. Praxis Impact Large Cap Value ETF accounts for about 2.2% of EverSource Wealth Advisors LLC’s holdings, making the stock its 5th largest position. EverSource Wealth Advisors LLC owned about 111.44% of Praxis Impact Large Cap Value ETF worth $73,454,000 as of its most recent filing with the SEC.

Praxis Impact Large Cap Value ETF Stock Performance

PRXV stock traded up $0.41 during midday trading on Thursday, reaching $35.14. 4,644 shares of the company’s stock traded hands, compared to its average volume of 5,815. The company has a 50-day moving average price of $33.46 and a two-hundred day moving average price of $32.14. Praxis Impact Large Cap Value ETF has a 52 week low of $28.00 and a 52 week high of $35.57. The firm has a market capitalization of $74.50 million, a PE ratio of 18.61 and a beta of 0.50.

Praxis Impact Large Cap Value ETF Company Profile

The Praxis Impact Large Cap Value ETF (PRXV) is an exchange-traded fund that is based on the CRSP US Large Cap Value index. The Praxis Impact Large Cap Value ETF seeks capital appreciation. PRXV was launched on Apr 8, 2025 and is issued by Praxis.